Results 151 to 160 of about 13,244 (270)
Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma. [PDF]
Smith SD +12 more
europepmc +1 more source
Despite growing efforts to bring Indigenous and Western knowledge together in caribou research, inconsistent reporting of collaboration, ethics, knowledge sharing and Indigenous governance over data continue to limit transparency, accountability and true co‐production of knowledge.
Kimberly Klenk +14 more
wiley +1 more source
Combining space use with diet data to investigate foraging tactics of black bears in response to the pulsed availability of migratory caribou calves. [PDF]
Nowack L +7 more
europepmc +1 more source
This is a review of the short film, Tuktuit: Caribou (2026), directed by Lindsay Aksarniq McIntyre.
openaire +1 more source
Humans are not unique: difficult birth is common in placental mammals
ABSTRACT Human childbirth is widely presumed to be uniquely difficult and dangerous compared to birth in other mammals. Tight fetopelvic proportions can result in obstructed labour and contribute to high rates of maternal and neonatal mortality. Ideas summarised under the ‘obstetrical dilemma’ have contributed to this assumption by explaining difficult
Nicole D. S. Grunstra
wiley +1 more source
Disturbance-mediated apparent competition across boreal landscapes: the role of primary productivity. [PDF]
Neufeld BT +4 more
europepmc +1 more source
ABSTRACT Chemoimmunotherapy (CIT) had long been used to treat chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) until 2014 when the first novel agent, ibrutinib, was approved in the United States. Numerous novel therapies have since become available.
Mengyang Di +8 more
wiley +1 more source
Dynamic Lake Ice Conditions Shape Caribou Water-Crossing Behavior in the Arctic. [PDF]
Liao Q, Gurarie E, Fagan WF.
europepmc +1 more source
Abstract Background Ciltacabtagene autoleucel (cilta‐cel), an anti–B‐cell maturation antigen (BCMA) chimeric antigen receptor T‐cell (CAR‐T) therapy, is approved for relapsed/refractory multiple myeloma (RRMM). Methods Using the Center for International Blood and Marrow Transplant Research registry, this study evaluated outcomes of frail patients ...
Hira Mian +31 more
wiley +1 more source
A Gnawing Question: How Do Caribou and Other Arctic Mammals Exploit Shared Bone Resources? [PDF]
Gaetano M +3 more
europepmc +1 more source

